AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own American Healthcare REIT, you need to believe in the long term need for senior housing and medical real estate, and the company’s ability to convert that demand into steady earnings and distributions. The recent US$712.19 million equity raise expands balance sheet capacity and supports growth, but also adds dilution risk, which now sits alongside slower incremental growth potential in Trilogy and SHOP as a key issue to watch in the near term.
The fresh capital comes just as American Healthcare REIT reported sharply higher net income and raised its 2026 earnings guidance, helped by lower real estate impairment charges. That combination of improved profitability and added financial flexibility links directly to the main catalyst for the stock: continued execution on acquisitions and portfolio optimization without overreaching on leverage or overpaying for non stabilized assets.
But against this stronger balance sheet, investors should still be aware of the risk that acquisition integration and stabilization could...
Read the full narrative on American Healthcare REIT (it's free!)
American Healthcare REIT's narrative projects $3.2 billion revenue and $277.6 million earnings by 2029.
Uncover how American Healthcare REIT's forecasts yield a $61.53 fair value, a 13% upside to its current price.
Two fair value estimates from the Simply Wall St Community span roughly US$61.53 to US$117.11, showing how differently private investors assess American Healthcare REIT. You can weigh those views against the recent equity raise and its potential to support acquisitions while increasing dilution risk to judge how the business might perform over time.
Explore 2 other fair value estimates on American Healthcare REIT - why the stock might be worth over 2x more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com